The Transnational Institute (TNI) attends the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. This storify features tweets, blogs and news from the event. Our team in Vienna includes Martin Jelsma, Pien Metaal and Tom Blickman.
The 7th GIZ/TNI Asian Informal Drug Policy Dialogue was organised in collaboration with the National Authority for Combating Drugs (NACD) of the Cambodian Government. Key issues on the agenda were recent trends in the drug market in the region and the development of effective policy responses. Specific attention went to the implementation of the UN Guiding Principles on Alternative Development in the Asian context, including in the implementation of alternative development programmes in conflict areas. The involvement of affected communities in policy making and project implementation was another important theme that was discussed. A major aim of the dialogue was to look at the state of the Asian drug policy before UNGASS 2016.
The year 2011 marks the 50th anniversary of the 1961 Single Convention on Narcotic Drugs (CND), the bedrock of the current UN drug control system. TNI will host a side event at the 54th session of the Commission on Narcotic Drugs. Several speakers will critically examine the significance and shortcomings of the Convention, explain how plants and traditional use are treated under its provisions, and discuss the current state of affairs of Bolivia's amendment proposal on coca chewing.
Bolivia has denounced the International Convention on Narcotic Drugs, which bans the traditional practice of chewing coca leaf. Adam talks with Martin Jelsma, who coordinates the Drugs and Democracy Program at the Amsterdam-based Transnational Institute.
Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.
By 1998, when the United Nations convened a special General Assembly on drugs, there was already overwhelming evidence that the current approach to global drugs control had failed miserably, given the continuing rise in consumption and production. However, the evidence was ignored and no evaluation of what was wrong with current drug policy took place. Instead, as a New York Times editorial noted, unrealistic pledges were recycled, this time aiming at eliminating all drug production by the year 2008. In mid-April this year, the mid-term review of the goals and targets set by the special session on drugs is to take place in Vienna.
On March 12, 2009, the President of Bolivia, Evo Morales, sent a letter sent a letter to the Secretary General of the United Nations, Ban Ki Moon, requesting the suspension of the paragraphs 1c and 2e of Article 49 of 1961 UN Single Convention that prohibit the traditional chewing of coca leaf.
In 1995 the World Health Organization (WHO) and the United Nations Interregional Crime and Justice Research Institute (UNICRI) announced in a press release the publication of the results of the largest global study on cocaine use ever undertaken.
In January 2019 the World Health Organization issued a collection of formal recommendations to reschedule cannabis and cannabis-related substances. 53 member states of the Commission on Narcotic Drugs (CND) are set to vote on these recommendations in December 2020.
The Executive Director of the UNODC, Mr Antonio Maria Costa, released a progress report, "Encouraging progress towards still distant goals", as a Contribution to the Mid-term (2003) Review of UNGASS. The report examines whether the international community is on track to reduce illicit drug production, trafficking and abuse. TNI reviewed the UN report.
This IDPC response to the United Nations Office on Drugs and Crime (UNODC)’s flagship publication, the World Drug Report, provides an overview of the data and topics presented in the Report and where appropriate, within the broader context of the current state of the UN drug control framework, offer a critical analysis of both.
From 16 to 18 October 2019, representatives of member states, intergovernmental organisations, and civil society attended the 6th Intersessional Meeting of the Commission on Narcotic Drugs. On 17 October 2019, representatives of coca and opium growers from Colombia and Myanmar delivered statements highlighting the situation of communities involved in the illicit cultivation of coca and opium in both countries. Below are their full statements.
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
It is no understatement to claim that there are few plants subject to such tensions as the coca leaf, either in legal and political circuits, or in the medical and anthropological academic world. Before, during and after its inclusion in the number 1 list of the Single Convention on Narcotic Drugs of 1961, the controversy on whether the coca leaf is or is not to be considered a narcotic drug, worthy of control by the international institutions and mechanisms, reached apparent irreconcilable positions.
No sería una exageración destacar que pocas plantas han suscitado tanta tensión como la hoja de coca, tanto en el ambiente político-jurídico, como en el mundo académico médico y antropológico. Antes, durante y después de su inclusión en la Lista 1 de la Convención Única de 1961 sobre Estupefacientes, la controversia sobre si se debía considerar la hoja de coca como estupefaciente digno de fiscalización por parte de los organismos encargados del control internacional de drogas, llegó a posiciones aparentemente irreconciliables.
The United Nations Drugs Control Programme (UNDCP) is rallying support for the UN General Assembly Special Session to Counter the World Drug Problem Together (UNGASS). The UNDCP hopes the meeting will raise the profile of drugs issues and place the agency at the centre of a revitalised global approach to drugs. At the meeting, a series of declarations and action plans on a variety of issues will be tabled. Tackling drugs problems, however, involves more than words. What matters most is how such ideas will be put into action.
This briefing paper looks at the issues raised by the publication in June of the latest World Drug Report by the United Nations Office on Drugs and Crime. The briefing paper analyses the developing data collection methodologies used by the UNODC and, while recognising their limitations, summarises the findings of the 2006 report on trends in the demand and supply of the main types of internationally prohibited drugs.
This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.